128 Additionally, thalidomide inhibits M1 macrophage polarization by targeting the transcription factor IRF5, reduces the release of inflammatory signals, significantly reduces the secretion of the proinflammatory cytokines IL-12 and IFN-, and promotes intestinal mucosal healing
Results: Among 818,892 Veterans with abdominal imaging, the algorithm identified 299,259 participants with MASLD (36.5%), 99,163 with MetALD (12.1%), 38,552 (4.7%) with ALD
The foundation's Canadian survey found that 51 percent of employers now cover GLP-1 drugs for diabetes alone, down from 56 percent in 2025 and 66 percent in 2024
Still on a GLP-1 Book: Jun 17, 2026 Jun 17, 2026 12 min Three years
The orforglipron vs tirzepatide comparison discusses how this new medication may change the oral GLP-1 landscape